NISA INVESTMENT ADVISORS, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,319
-88.1%
550
-72.9%
0.00%
-100.0%
Q2 2023$95,404
+153777.4%
2,029
+36.3%
0.00%
Q1 2023$62
+8.8%
1,4890.0%0.00%
Q4 2022$57
-99.9%
1,489
-8.6%
0.00%
-100.0%
Q3 2022$61,000
+22.0%
1,629
+5.8%
0.00%
Q2 2022$50,000
+1566.7%
1,539
+1629.2%
0.00%
Q1 2022$3,000
-62.5%
89
-58.4%
0.00%
Q4 2021$8,000
-46.7%
214
-36.1%
0.00%
Q3 2021$15,000
-87.1%
335
-83.6%
0.00%
-100.0%
Q2 2021$116,000
-47.3%
2,037
-30.6%
0.00%0.0%
Q1 2021$220,000
-13.4%
2,9370.0%0.00%
-50.0%
Q4 2020$254,000
+303.2%
2,937
+186.5%
0.00%
+100.0%
Q3 2020$63,000
+46.5%
1,0250.0%0.00%
Q2 2020$43,000
-68.6%
1,025
-78.4%
0.00%
-100.0%
Q1 2020$137,000
-52.6%
4,755
+18.7%
0.00%0.0%
Q4 2019$289,000
-87.7%
4,005
-76.1%
0.00%
-90.5%
Q3 2019$2,352,000
+7250.0%
16,765
+9480.0%
0.02%
Q2 2019$32,000
+14.3%
1750.0%0.00%
Q1 2019$28,000
-86.1%
175
-91.7%
0.00%
-100.0%
Q4 2018$202,000
-32.0%
2,1050.0%0.00%
-33.3%
Q3 2018$297,000
+1000.0%
2,105
+1102.9%
0.00%
Q2 2018$27,000
-57.8%
175
-56.2%
0.00%
-100.0%
Q1 2018$64,000
-13.5%
400
-11.1%
0.00%0.0%
Q4 2017$74,000
+184.6%
450
+9.8%
0.00%
Q3 2017$26,000
-21.2%
4100.0%0.00%
Q2 2017$33,000
+13.8%
4100.0%0.00%
Q1 2017$29,000
+45.0%
410
+2.5%
0.00%
Q4 2016$20,0004000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders